Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
APGE
APGE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
APGE News
Apogee Therapeutics Reports 2025 Financial Results and Pipeline Progress
Mar 03 2026
NASDAQ.COM
Apogee Therapeutics Reports FY Net Loss of $255.8M
Mar 02 2026
seekingalpha
Great Point Partners Increases Stake in Apogee Therapeutics
Feb 25 2026
Fool
Great Point Partners Increases Apogee Holdings by 70,000 Shares
Feb 25 2026
NASDAQ.COM
Apogee Therapeutics Announces Upcoming Conference Participation
Feb 24 2026
Newsfilter
Perceptive Advisors Increases Stake in Apogee Therapeutics
Feb 22 2026
Fool
Perceptive Advisors Acquires 431,432 Shares of Praxis Precision Medicines
Feb 22 2026
Yahoo Finance
Atopic Dermatitis Market Growth Insights
Feb 16 2026
Newsfilter
Affinity Asset Advisors Increases Stake in Apogee Therapeutics
Feb 14 2026
Fool
Apogee Therapeutics (APGE.US) Officer Plans to Sell $3.84 Million in Common Stock via Form 144
Feb 11 2026
moomoo
Apogee Therapeutics (APGE) Options Volume Surges 46.6% Today
Jan 23 2026
NASDAQ.COM
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Apogee Therapeutics CMO Sells $1.46 Million in Shares
Jan 11 2026
NASDAQ.COM
Apogee Therapeutics CMO Sells $1.46 Million in Shares Following Options Exercise
Jan 11 2026
Fool
Apogee Therapeutics CMO Sells 10,900 Shares for $817,500
Jan 08 2026
Fool
APGE Options Offer 9.33% Yield Boost on $75 Put Contract
Jan 07 2026
NASDAQ.COM
Show More News
